[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Drugs for Malaria Market Growth (Status and Outlook) 2024-2030

January 2024 | 90 pages | ID: G393A32D3076EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

According to our LPI (LP Information) latest study, the global Drugs for Malaria market size was valued at US$ million in 2023. With growing demand in downstream market, the Drugs for Malaria is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.

The research report highlights the growth potential of the global Drugs for Malaria market. Drugs for Malaria are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Drugs for Malaria. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Drugs for Malaria market.

Drugs for malaria or antimalarial medications are also known as anti-malarial drugs. Anti-malarial drugs treat or Prevention malaria, a disease that occurs in tropical, subtropical, and some temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of one-celled organisms known as protozoa. The only way to get malaria is to be bitten by a certain type of mosquito that has bitten someone who has the disease.

Anti-malarial Drugs are available only with a physician's prescription. They come in tablet, capsule, and injectable forms. Among the commonly used anti-malarial drugs are chloroquine, mefloquine, primaquine, pyrimethamine, and quinine.

In the U.S. market, the major manufacturers are Cipla, Guilin Southern Medicine, IPCA Laboratories, GlaxoSmithKline, Mylan Labs, Roche, Novartis, Sanofi Aentis and Ajanta Pharma, etc, with about 73% market shares.

Key Features:

The report on Drugs for Malaria market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the Drugs for Malaria market. It may include historical data, market segmentation by Type (e.g., Aryl Aminoalcohol Compounds, Antifolate Compounds), and regional breakdowns.

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Drugs for Malaria market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Competitive Landscape: The research report provides analysis of the competitive landscape within the Drugs for Malaria market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the Drugs for Malaria industry. This include advancements in Drugs for Malaria technology, Drugs for Malaria new entrants, Drugs for Malaria new investment, and other innovations that are shaping the future of Drugs for Malaria.

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Drugs for Malaria market. It includes factors influencing customer ' purchasing decisions, preferences for Drugs for Malaria product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Drugs for Malaria market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Drugs for Malaria market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Drugs for Malaria market.

Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Drugs for Malaria industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Drugs for Malaria market.

Market Segmentation:

Drugs for Malaria market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Segmentation by type
  • Aryl Aminoalcohol Compounds
  • Antifolate Compounds
  • Artemisinin Compounds
Segmentation by application
  • Prevention
  • Treatment
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Cipla
  • Guilin Pharmaceutical
  • IPCA Laboratories
  • GlaxoSmithKline
  • Mylan Labs
  • Roche
  • Novartis
  • Sanofi Aventis
  • Ajanta Pharma
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Drugs for Malaria Market Size 2019-2030
  2.1.2 Drugs for Malaria Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Drugs for Malaria Segment by Type
  2.2.1 Aryl Aminoalcohol Compounds
  2.2.2 Antifolate Compounds
  2.2.3 Artemisinin Compounds
2.3 Drugs for Malaria Market Size by Type
  2.3.1 Drugs for Malaria Market Size CAGR by Type (2019 VS 2023 VS 2030)
  2.3.2 Global Drugs for Malaria Market Size Market Share by Type (2019-2024)
2.4 Drugs for Malaria Segment by Application
  2.4.1 Prevention
  2.4.2 Treatment
  2.4.3 Others
2.5 Drugs for Malaria Market Size by Application
  2.5.1 Drugs for Malaria Market Size CAGR by Application (2019 VS 2023 VS 2030)
  2.5.2 Global Drugs for Malaria Market Size Market Share by Application (2019-2024)

3 DRUGS FOR MALARIA MARKET SIZE BY PLAYER

3.1 Drugs for Malaria Market Size Market Share by Players
  3.1.1 Global Drugs for Malaria Revenue by Players (2019-2024)
  3.1.2 Global Drugs for Malaria Revenue Market Share by Players (2019-2024)
3.2 Global Drugs for Malaria Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 DRUGS FOR MALARIA BY REGIONS

4.1 Drugs for Malaria Market Size by Regions (2019-2024)
4.2 Americas Drugs for Malaria Market Size Growth (2019-2024)
4.3 APAC Drugs for Malaria Market Size Growth (2019-2024)
4.4 Europe Drugs for Malaria Market Size Growth (2019-2024)
4.5 Middle East & Africa Drugs for Malaria Market Size Growth (2019-2024)

5 AMERICAS

5.1 Americas Drugs for Malaria Market Size by Country (2019-2024)
5.2 Americas Drugs for Malaria Market Size by Type (2019-2024)
5.3 Americas Drugs for Malaria Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Drugs for Malaria Market Size by Region (2019-2024)
6.2 APAC Drugs for Malaria Market Size by Type (2019-2024)
6.3 APAC Drugs for Malaria Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Drugs for Malaria by Country (2019-2024)
7.2 Europe Drugs for Malaria Market Size by Type (2019-2024)
7.3 Europe Drugs for Malaria Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Drugs for Malaria by Region (2019-2024)
8.2 Middle East & Africa Drugs for Malaria Market Size by Type (2019-2024)
8.3 Middle East & Africa Drugs for Malaria Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL DRUGS FOR MALARIA MARKET FORECAST

10.1 Global Drugs for Malaria Forecast by Regions (2025-2030)
  10.1.1 Global Drugs for Malaria Forecast by Regions (2025-2030)
  10.1.2 Americas Drugs for Malaria Forecast
  10.1.3 APAC Drugs for Malaria Forecast
  10.1.4 Europe Drugs for Malaria Forecast
  10.1.5 Middle East & Africa Drugs for Malaria Forecast
10.2 Americas Drugs for Malaria Forecast by Country (2025-2030)
  10.2.1 United States Drugs for Malaria Market Forecast
  10.2.2 Canada Drugs for Malaria Market Forecast
  10.2.3 Mexico Drugs for Malaria Market Forecast
  10.2.4 Brazil Drugs for Malaria Market Forecast
10.3 APAC Drugs for Malaria Forecast by Region (2025-2030)
  10.3.1 China Drugs for Malaria Market Forecast
  10.3.2 Japan Drugs for Malaria Market Forecast
  10.3.3 Korea Drugs for Malaria Market Forecast
  10.3.4 Southeast Asia Drugs for Malaria Market Forecast
  10.3.5 India Drugs for Malaria Market Forecast
  10.3.6 Australia Drugs for Malaria Market Forecast
10.4 Europe Drugs for Malaria Forecast by Country (2025-2030)
  10.4.1 Germany Drugs for Malaria Market Forecast
  10.4.2 France Drugs for Malaria Market Forecast
  10.4.3 UK Drugs for Malaria Market Forecast
  10.4.4 Italy Drugs for Malaria Market Forecast
  10.4.5 Russia Drugs for Malaria Market Forecast
10.5 Middle East & Africa Drugs for Malaria Forecast by Region (2025-2030)
  10.5.1 Egypt Drugs for Malaria Market Forecast
  10.5.2 South Africa Drugs for Malaria Market Forecast
  10.5.3 Israel Drugs for Malaria Market Forecast
  10.5.4 Turkey Drugs for Malaria Market Forecast
  10.5.5 GCC Countries Drugs for Malaria Market Forecast
10.6 Global Drugs for Malaria Forecast by Type (2025-2030)
10.7 Global Drugs for Malaria Forecast by Application (2025-2030)

11 KEY PLAYERS ANALYSIS

11.1 Cipla
  11.1.1 Cipla Company Information
  11.1.2 Cipla Drugs for Malaria Product Offered
  11.1.3 Cipla Drugs for Malaria Revenue, Gross Margin and Market Share (2019-2024)
  11.1.4 Cipla Main Business Overview
  11.1.5 Cipla Latest Developments
11.2 Guilin Pharmaceutical
  11.2.1 Guilin Pharmaceutical Company Information
  11.2.2 Guilin Pharmaceutical Drugs for Malaria Product Offered
  11.2.3 Guilin Pharmaceutical Drugs for Malaria Revenue, Gross Margin and Market Share (2019-2024)
  11.2.4 Guilin Pharmaceutical Main Business Overview
  11.2.5 Guilin Pharmaceutical Latest Developments
11.3 IPCA Laboratories
  11.3.1 IPCA Laboratories Company Information
  11.3.2 IPCA Laboratories Drugs for Malaria Product Offered
  11.3.3 IPCA Laboratories Drugs for Malaria Revenue, Gross Margin and Market Share (2019-2024)
  11.3.4 IPCA Laboratories Main Business Overview
  11.3.5 IPCA Laboratories Latest Developments
11.4 GlaxoSmithKline
  11.4.1 GlaxoSmithKline Company Information
  11.4.2 GlaxoSmithKline Drugs for Malaria Product Offered
  11.4.3 GlaxoSmithKline Drugs for Malaria Revenue, Gross Margin and Market Share (2019-2024)
  11.4.4 GlaxoSmithKline Main Business Overview
  11.4.5 GlaxoSmithKline Latest Developments
11.5 Mylan Labs
  11.5.1 Mylan Labs Company Information
  11.5.2 Mylan Labs Drugs for Malaria Product Offered
  11.5.3 Mylan Labs Drugs for Malaria Revenue, Gross Margin and Market Share (2019-2024)
  11.5.4 Mylan Labs Main Business Overview
  11.5.5 Mylan Labs Latest Developments
11.6 Roche
  11.6.1 Roche Company Information
  11.6.2 Roche Drugs for Malaria Product Offered
  11.6.3 Roche Drugs for Malaria Revenue, Gross Margin and Market Share (2019-2024)
  11.6.4 Roche Main Business Overview
  11.6.5 Roche Latest Developments
11.7 Novartis
  11.7.1 Novartis Company Information
  11.7.2 Novartis Drugs for Malaria Product Offered
  11.7.3 Novartis Drugs for Malaria Revenue, Gross Margin and Market Share (2019-2024)
  11.7.4 Novartis Main Business Overview
  11.7.5 Novartis Latest Developments
11.8 Sanofi Aventis
  11.8.1 Sanofi Aventis Company Information
  11.8.2 Sanofi Aventis Drugs for Malaria Product Offered
  11.8.3 Sanofi Aventis Drugs for Malaria Revenue, Gross Margin and Market Share (2019-2024)
  11.8.4 Sanofi Aventis Main Business Overview
  11.8.5 Sanofi Aventis Latest Developments
11.9 Ajanta Pharma
  11.9.1 Ajanta Pharma Company Information
  11.9.2 Ajanta Pharma Drugs for Malaria Product Offered
  11.9.3 Ajanta Pharma Drugs for Malaria Revenue, Gross Margin and Market Share (2019-2024)
  11.9.4 Ajanta Pharma Main Business Overview
  11.9.5 Ajanta Pharma Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION


LIST OF TABLES

Table 1. Drugs for Malaria Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Aryl Aminoalcohol Compounds
Table 3. Major Players of Antifolate Compounds
Table 4. Major Players of Artemisinin Compounds
Table 5. Drugs for Malaria Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 6. Global Drugs for Malaria Market Size by Type (2019-2024) & ($ Millions)
Table 7. Global Drugs for Malaria Market Size Market Share by Type (2019-2024)
Table 8. Drugs for Malaria Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Drugs for Malaria Market Size by Application (2019-2024) & ($ Millions)
Table 10. Global Drugs for Malaria Market Size Market Share by Application (2019-2024)
Table 11. Global Drugs for Malaria Revenue by Players (2019-2024) & ($ Millions)
Table 12. Global Drugs for Malaria Revenue Market Share by Player (2019-2024)
Table 13. Drugs for Malaria Key Players Head office and Products Offered
Table 14. Drugs for Malaria Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Drugs for Malaria Market Size by Regions 2019-2024 & ($ Millions)
Table 18. Global Drugs for Malaria Market Size Market Share by Regions (2019-2024)
Table 19. Global Drugs for Malaria Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Drugs for Malaria Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Drugs for Malaria Market Size by Country (2019-2024) & ($ Millions)
Table 22. Americas Drugs for Malaria Market Size Market Share by Country (2019-2024)
Table 23. Americas Drugs for Malaria Market Size by Type (2019-2024) & ($ Millions)
Table 24. Americas Drugs for Malaria Market Size Market Share by Type (2019-2024)
Table 25. Americas Drugs for Malaria Market Size by Application (2019-2024) & ($ Millions)
Table 26. Americas Drugs for Malaria Market Size Market Share by Application (2019-2024)
Table 27. APAC Drugs for Malaria Market Size by Region (2019-2024) & ($ Millions)
Table 28. APAC Drugs for Malaria Market Size Market Share by Region (2019-2024)
Table 29. APAC Drugs for Malaria Market Size by Type (2019-2024) & ($ Millions)
Table 30. APAC Drugs for Malaria Market Size Market Share by Type (2019-2024)
Table 31. APAC Drugs for Malaria Market Size by Application (2019-2024) & ($ Millions)
Table 32. APAC Drugs for Malaria Market Size Market Share by Application (2019-2024)
Table 33. Europe Drugs for Malaria Market Size by Country (2019-2024) & ($ Millions)
Table 34. Europe Drugs for Malaria Market Size Market Share by Country (2019-2024)
Table 35. Europe Drugs for Malaria Market Size by Type (2019-2024) & ($ Millions)
Table 36. Europe Drugs for Malaria Market Size Market Share by Type (2019-2024)
Table 37. Europe Drugs for Malaria Market Size by Application (2019-2024) & ($ Millions)
Table 38. Europe Drugs for Malaria Market Size Market Share by Application (2019-2024)
Table 39. Middle East & Africa Drugs for Malaria Market Size by Region (2019-2024) & ($ Millions)
Table 40. Middle East & Africa Drugs for Malaria Market Size Market Share by Region (2019-2024)
Table 41. Middle East & Africa Drugs for Malaria Market Size by Type (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Drugs for Malaria Market Size Market Share by Type (2019-2024)
Table 43. Middle East & Africa Drugs for Malaria Market Size by Application (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Drugs for Malaria Market Size Market Share by Application (2019-2024)
Table 45. Key Market Drivers & Growth Opportunities of Drugs for Malaria
Table 46. Key Market Challenges & Risks of Drugs for Malaria
Table 47. Key Industry Trends of Drugs for Malaria
Table 48. Global Drugs for Malaria Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 49. Global Drugs for Malaria Market Size Market Share Forecast by Regions (2025-2030)
Table 50. Global Drugs for Malaria Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 51. Global Drugs for Malaria Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 52. Cipla Details, Company Type, Drugs for Malaria Area Served and Its Competitors
Table 53. Cipla Drugs for Malaria Product Offered
Table 54. Cipla Drugs for Malaria Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Cipla Main Business
Table 56. Cipla Latest Developments
Table 57. Guilin Pharmaceutical Details, Company Type, Drugs for Malaria Area Served and Its Competitors
Table 58. Guilin Pharmaceutical Drugs for Malaria Product Offered
Table 59. Guilin Pharmaceutical Main Business
Table 60. Guilin Pharmaceutical Drugs for Malaria Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. Guilin Pharmaceutical Latest Developments
Table 62. IPCA Laboratories Details, Company Type, Drugs for Malaria Area Served and Its Competitors
Table 63. IPCA Laboratories Drugs for Malaria Product Offered
Table 64. IPCA Laboratories Main Business
Table 65. IPCA Laboratories Drugs for Malaria Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. IPCA Laboratories Latest Developments
Table 67. GlaxoSmithKline Details, Company Type, Drugs for Malaria Area Served and Its Competitors
Table 68. GlaxoSmithKline Drugs for Malaria Product Offered
Table 69. GlaxoSmithKline Main Business
Table 70. GlaxoSmithKline Drugs for Malaria Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. GlaxoSmithKline Latest Developments
Table 72. Mylan Labs Details, Company Type, Drugs for Malaria Area Served and Its Competitors
Table 73. Mylan Labs Drugs for Malaria Product Offered
Table 74. Mylan Labs Main Business
Table 75. Mylan Labs Drugs for Malaria Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. Mylan Labs Latest Developments
Table 77. Roche Details, Company Type, Drugs for Malaria Area Served and Its Competitors
Table 78. Roche Drugs for Malaria Product Offered
Table 79. Roche Main Business
Table 80. Roche Drugs for Malaria Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. Roche Latest Developments
Table 82. Novartis Details, Company Type, Drugs for Malaria Area Served and Its Competitors
Table 83. Novartis Drugs for Malaria Product Offered
Table 84. Novartis Main Business
Table 85. Novartis Drugs for Malaria Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. Novartis Latest Developments
Table 87. Sanofi Aventis Details, Company Type, Drugs for Malaria Area Served and Its Competitors
Table 88. Sanofi Aventis Drugs for Malaria Product Offered
Table 89. Sanofi Aventis Main Business
Table 90. Sanofi Aventis Drugs for Malaria Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. Sanofi Aventis Latest Developments
Table 92. Ajanta Pharma Details, Company Type, Drugs for Malaria Area Served and Its Competitors
Table 93. Ajanta Pharma Drugs for Malaria Product Offered
Table 94. Ajanta Pharma Main Business
Table 95. Ajanta Pharma Drugs for Malaria Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 96. Ajanta Pharma Latest Developments

LIST OF FIGURES

Figure 1. Drugs for Malaria Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Drugs for Malaria Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Drugs for Malaria Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Drugs for Malaria Sales Market Share by Country/Region (2023)
Figure 8. Drugs for Malaria Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Drugs for Malaria Market Size Market Share by Type in 2023
Figure 10. Drugs for Malaria in Prevention
Figure 11. Global Drugs for Malaria Market: Prevention (2019-2024) & ($ Millions)
Figure 12. Drugs for Malaria in Treatment
Figure 13. Global Drugs for Malaria Market: Treatment (2019-2024) & ($ Millions)
Figure 14. Drugs for Malaria in Others
Figure 15. Global Drugs for Malaria Market: Others (2019-2024) & ($ Millions)
Figure 16. Global Drugs for Malaria Market Size Market Share by Application in 2023
Figure 17. Global Drugs for Malaria Revenue Market Share by Player in 2023
Figure 18. Global Drugs for Malaria Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Drugs for Malaria Market Size 2019-2024 ($ Millions)
Figure 20. APAC Drugs for Malaria Market Size 2019-2024 ($ Millions)
Figure 21. Europe Drugs for Malaria Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Drugs for Malaria Market Size 2019-2024 ($ Millions)
Figure 23. Americas Drugs for Malaria Value Market Share by Country in 2023
Figure 24. United States Drugs for Malaria Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Drugs for Malaria Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Drugs for Malaria Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Drugs for Malaria Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Drugs for Malaria Market Size Market Share by Region in 2023
Figure 29. APAC Drugs for Malaria Market Size Market Share by Type in 2023
Figure 30. APAC Drugs for Malaria Market Size Market Share by Application in 2023
Figure 31. China Drugs for Malaria Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Drugs for Malaria Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Drugs for Malaria Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Drugs for Malaria Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Drugs for Malaria Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Drugs for Malaria Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Drugs for Malaria Market Size Market Share by Country in 2023
Figure 38. Europe Drugs for Malaria Market Size Market Share by Type (2019-2024)
Figure 39. Europe Drugs for Malaria Market Size Market Share by Application (2019-2024)
Figure 40. Germany Drugs for Malaria Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Drugs for Malaria Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Drugs for Malaria Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Drugs for Malaria Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Drugs for Malaria Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Drugs for Malaria Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Drugs for Malaria Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Drugs for Malaria Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Drugs for Malaria Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Drugs for Malaria Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Drugs for Malaria Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Drugs for Malaria Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Drugs for Malaria Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Drugs for Malaria Market Size 2025-2030 ($ Millions)
Figure 54. APAC Drugs for Malaria Market Size 2025-2030 ($ Millions)
Figure 55. Europe Drugs for Malaria Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Drugs for Malaria Market Size 2025-2030 ($ Millions)
Figure 57. United States Drugs for Malaria Market Size 2025-2030 ($ Millions)
Figure 58. Canada Drugs for Malaria Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Drugs for Malaria Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Drugs for Malaria Market Size 2025-2030 ($ Millions)
Figure 61. China Drugs for Malaria Market Size 2025-2030 ($ Millions)
Figure 62. Japan Drugs for Malaria Market Size 2025-2030 ($ Millions)
Figure 63. Korea Drugs for Malaria Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Drugs for Malaria Market Size 2025-2030 ($ Millions)
Figure 65. India Drugs for Malaria Market Size 2025-2030 ($ Millions)
Figure 66. Australia Drugs for Malaria Market Size 2025-2030 ($ Millions)
Figure 67. Germany Drugs for Malaria Market Size 2025-2030 ($ Millions)
Figure 68. France Drugs for Malaria Market Size 2025-2030 ($ Millions)
Figure 69. UK Drugs for Malaria Market Size 2025-2030 ($ Millions)
Figure 70. Italy Drugs for Malaria Market Size 2025-2030 ($ Millions)
Figure 71. Russia Drugs for Malaria Market Size 2025-2030 ($ Millions)
Figure 72. Spain Drugs for Malaria Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Drugs for Malaria Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Drugs for Malaria Market Size 2025-2030 ($ Millions)
Figure 75. Israel Drugs for Malaria Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Drugs for Malaria Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Drugs for Malaria Market Size 2025-2030 ($ Millions)
Figure 78. Global Drugs for Malaria Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Drugs for Malaria Market Size Market Share Forecast by Application (2025-2030)


More Publications